Multiply antibiotic-resistant Staphylococcus aureus: introduction, transmission, and evolution of nosocomial

Annals of Internal Medicine
|September 1, 1982
PubMed

Insights

A multiply antibiotic-resistant Staphylococcus aureus strain spread to 34 patients, causing severe infections and deaths. The outbreak was controlled by adding rifampin to vancomycin treatment, eradicating the carrier state.

Area of Science:

  • Infectious Diseases
  • Medical Microbiology
  • Hospital Epidemiology

Background:

  • A multiply antibiotic-resistant Staphylococcus aureus (MRSA) strain was introduced into a hospital setting by an inter-state transfer burn patient.
  • The MRSA strain subsequently transmitted to 34 patients over 15 months, despite adherence to standard wound precautions.

Observation:

  • Infections included pneumonia, empyema, bacteremia, endocarditis, osteomyelitis, and burn/wound infections, with a mortality rate of 50% (17 of 34 patients).
  • The transmission occurred from a burn unit to a surgical intensive care unit (SICU) involved in a chloramphenicol study for bowel sepsis.
  • The MRSA acquired chloramphenicol resistance by acquiring R-plasmids, leading to four distinct epidemic strains identified through phage typing, plasmid analysis, and antibiograms.

Findings:

  • Phage typing and plasmid analysis confirmed the spread of MRSA between units and identified patient and personnel reservoirs.
  • The emergence of chloramphenicol resistance in the MRSA strain complicated treatment and facilitated its spread.
  • The outbreak was successfully controlled by adding rifampin to vancomycin therapy for infected patients, leading to the eradication of the carrier state.

Implications:

  • This case highlights the significant threat posed by multiply antibiotic-resistant organisms in healthcare settings.
  • Effective control requires comprehensive infection surveillance, rapid diagnostics, and targeted antimicrobial stewardship.
  • The study underscores the importance of understanding resistance mechanisms and transmission dynamics for outbreak management.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
48.9K
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
11.6K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
143
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90